- This topic has 0 replies, 1 voice, and was last updated 8 years, 1 month ago by
.
-
Posts
-
Hi all,
I came about this information about a month or so ago, I was looking for something to help lose some stubborn weight and came across this. Seems this compound has the ability to do that and a whole lot more, including slowing down/kicking back the aging clock and positively affecting autoimmune diseases, with some form of clinical trials to back this up. I have been using it for about a month so far, have lost 8 lbs and my energy level has increased quite a bit. As far as my autoimmune issues, nothing to say on that since I continue taking my supplements and am still in remission, but hopefully this will lessen the likelihood of my coming out of remission in the future.
The chemical name of this supplement is Nicotinamide Riboside (NR) and it increases levels of NAD+ which affects mitochondria, the powerhouse of the cell, it increases their communications and rejuvenation, which is one of the issues that causes aging and many diseases. There is a lot of info to present, so rather that type out all of this I will provide some links to get you started. You will find so much more info in Pubmed and other articles on the web, so I suggest you do some research. There are a few companies selling this supplement, but all receive the raw materials from a company called Chromadex (HPN) which has the license. Some names of supplements are Niagen and Niacel. The compound was developed jointly by Harvard and Cornell. I highly recommend you add this to the Antibiotic Protocol for a winning combination against your autoimmune issues with some additional benefits. Good Luck to All.
John
http://www.nicotinamide-riboside.net/
http://www.lifeextension.com/magazine/2014/11/the-youth-restoring-benefits-of-nad/page-01
http://www.eurekalert.org/pub_releases/2014-10/bawh-anp100114.php
http://modernlifereview.com/nicotinamide-riboside-anti-aging-scam/
http://www.nature.com/ncomms/2014/141007/ncomms6101/full/ncomms6101.html
You must be logged in to reply to this topic.